Additionally, we confirmed that, in vivo, CDC42 overexpression led to enhanced tumor infiltration, IFN-γ production, and anti-tumor efficacy of iNKT cells (Fig. 6o–s). The gene discussed is CDC42; the disease is neoplasm.